Altasciences Featured Content

  1. Psychedelics And Entactogens: Challenges Associated With Schedule 1 Therapeutic Development 5/9/2025

    Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.

  2. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  3. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

  4. The Complexities Of Early Phase Ophthalmic Drug Development 2/20/2025

    Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.

  5. Factors Affecting Systemic Drug Exposure 1/22/2025

    The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.

  6. Managing The Complexities Of Glucagon-Like Peptide-1 Receptor Agonist Drug Development 11/20/2024

    Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead and the complexities of early-phase drug development.

  7. Toxicokinetics, Pharmacokinetics, And Pharmacodynamics 11/20/2024

    Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.

  8. Mental Health: 5 Facts About Psychedelics 10/16/2024

    As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.

  9. 5 Ways Integrated Drug Development Solutions Save Time And Money 10/16/2024

    See how this approach can cut research timelines by up to 40%, helping sponsors efficiently navigate early-phase drug development.

  10. How To Optimize Early-Phase Drug Development 10/16/2024

    Do you keep hitting roadblocks? Frustrated with all the paperwork? Let us help! Learn how Altasciences can provide a more seamless and efficient drug development experience.